Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Begs Vets To Stick With Its Animal Meds
Pharmalot
Thursday, August 30, 2012 - 9:52am
tags:
Novartis, animal health
4 Cash Loaded Biotech Stocks With Little Debt
Seeking Alpha
Thursday, August 30, 2012 - 9:48am
tags:
Obagi Medical Products, Cyclacel, Vanda, 3SBio
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thursday, August 30, 2012 - 9:46am
tags:
Exelixis, cabozantinib, medullary thyroid cancer
Charles River Labs buys microbial identification testing company Accugenix for $17 million
Yahoo/AP
Thursday, August 30, 2012 - 9:42am
tags:
Charles River Laboratories, M&A, Accugenix
Sequenom Expands Its International Reach
Motley Fool
Thursday, August 30, 2012 - 9:42am
tags:
Sequenom, Maternit21 Plus
POZEN's PA32540 shows posiive results in a Phase 1 study
Yahoo/Fly on the Wall
Thursday, August 30, 2012 - 9:41am
tags:
Pozen, PA32540
Showtime Is Drawing Near for This Drug: Dynavax's Heplisav
Motley Fool
Thursday, August 30, 2012 - 9:39am
tags:
Heplisav, Dynavax, vaccines, hepatitis B
Genmab, Johnson & Johnson agree $1.1 billion cancer deal
Reuters
Thursday, August 30, 2012 - 9:38am
tags:
Genman, JNJ, daratumumab, cancer
Abbott' Humira: A Much-Needed Win for This Blockbuster Drug
Motley Fool
Thursday, August 30, 2012 - 9:37am
tags:
Humira, Abbott, ulcerative colitis
Ariad Pharmaceuticals Gearing Up For Ponatinib's Approval
Seeking Alpha
Wednesday, August 29, 2012 - 5:54pm
tags:
Ariad Pharmaceuticals, Ponatinib, Pfizer, Bristol-Myers Squibb, Novartis
FDA approves wider use for J&J Nucynta ER pain drug
Reuters
Wednesday, August 29, 2012 - 5:47pm
tags:
FDA, JNJ, Nucynta, painkillers
What Lilly's Failure Means For Addex
Seeking Alpha
Wednesday, August 29, 2012 - 5:46pm
tags:
Addex, Eli Lilly, schizophrenia, LY2140023, pomaglumetad methionil, ADX71149, JNJ
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wednesday, August 29, 2012 - 12:21pm
tags:
Big Pharma, Lipitor, Anacetrapib, Merck, Plavix, Pfizer, Bristol-Myers Squibb, PCSK9 inhibitor, Sanofi, Regeneron, darapladib, Roche, GSK
The Next Catalyst For Arena
Seeking Alpha
Wednesday, August 29, 2012 - 12:19pm
tags:
Arena Pharmaceuticals, Belviq
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wednesday, August 29, 2012 - 12:17pm
tags:
Arqule, lung cancer, tivantinib
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
Wednesday, August 29, 2012 - 12:15pm
tags:
cataracts, FDA, cystic fibrosis, Vertex, Kalydeco
Pfizer Gets Creative Replacing Revenue Losses In 2012
Seeking Alpha
Wednesday, August 29, 2012 - 12:14pm
tags:
Pfizer
3 Things to Watch With ImmunoGen
Motley Fool
Wednesday, August 29, 2012 - 12:13pm
tags:
Immunogen
Will Pharma Companies Get Out of Alzheimer's Disease R&D?
Forbes
Wednesday, August 29, 2012 - 12:13pm
tags:
R&D, Alzheimer's disease, Eli Lilly, Pfizer, JNJ
Novartis Smoker’s Cough Treatment Beats Glaxo’s Advair in Trial
Bloomberg Businessweek
Wednesday, August 29, 2012 - 10:49am
tags:
Novartis, COP, GSK, Advair, smoker's cough, QVA149

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.